Survivin 96-104 (HLA-A*02:01)

Survivin 96-104 (HLA-A*02:01)
€50.00 *

Prices plus VAT plus shipping costs

Delivery time 2-3 days
sterile and endotoxin free Delivery Format:
The product is supplied freeze dried as trifluoracetate salt

Amount in mg:

5 mg

  • EP11422_1
LMLGEFLKL is a linear peptidic epitope (epitope ID38060), tested in T cell assays. The vector of... more
Product information "Survivin 96-104 (HLA-A*02:01)"
LMLGEFLKL is a linear peptidic epitope (epitope ID38060), tested in T cell assays. The vector of anti-Survivin T cell receptor (TCR) is constructed for the engineering of T cell to target Human Survivin. The T cells are genetically modified through transduction with a retroviral vector expressing Survivin-specific T cell receptor. And the vector product was designed for the treatment of diseases involving malignant cells expressing survivin.

 
Sequence:LMLGEFLKL
Delivery: 2-3 days
C-Terminus:OH
N-Terminus:H
Purity:95%
Amount:1 mg
Counter Ion:TFA
Protein:Survivin
Species:Human
Allele:HLA-A*02:01
Application :Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry
Indication :AIDS, Autoimmune disease, Breast cancer, Cancer, Cancer chemotherapy, Control, Diabetes, Graft-vs-host disease, Hematopoetic system, Hepatitis, Infection, Malaria, Malignant genital cancers, Melanoma, Prostate cancer, Testis/ovary cancer, Tuberculosis, Transplantation, Vaccination, Wilms tumor 1
Viewed